07/02/2006

Breast cancer sufferer faces wait on drug ruling

A breast cancer sufferer will have to wait to learn the result of her legal battle against the NHS' decision not to provide her with the drug, Herceptin.

Ann Marie Rogers, 54, from Swindon, launched her case after being refused the drug, which is only licensed for the treatment of advanced breast cancer, by Swindon Primary Care Trust.

However, a High Court Judge said that he would not decide on the case immediately, because the decision was "too important".

Ms Rogers' case is the first case to come to court. If she is successful, it could lead to all PCTs being forced to provide the drug for all patients with early-stage breast cancer.

Pressure has been mounting on the NHS to provide Herceptin for patients in the early stages of breast cancer. In two other previous cases, the NHS agreed to provide the drug, which costs around £20,000 per year's treatment.

Ms Rogers had borrowed £5,000 for Herceptin treatment, but cannot afford to fund any more courses.

Launching the case at the High Court yesterday, Ms Rogers' solicitor Ian Wise said that the Trust's policy of only providing Herceptin in "exceptional cases" was "arbitrary and unlawful".

In a statement, Ms Rogers said that she felt "as though I have been given a punishment like a death sentence" and added "waiting for the cancer to return is like waiting on death row."

(KMcA)

Related UK National News Stories
Click here for the latest headlines.

17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
06 February 2006
Cancer drug refusal branded a 'death sentence'
A woman who has launched a landmark legal challenge to get breast cancer drug Herceptin, has compared her NHS Trust's refusal to provide the drug as a "death sentence". Ann Marie Rogers, 54, from Swindon launched the case after being refused the drug by Swindon Primary Care Trust, which is only licensed for the treatment of advanced breast cancer.
13 June 2008
'Denied' Cancer Drug Now Available
A costly cancer drug that could have prolonged the life of a patient is now being made widely available in the UK. However, it is too late for charity-fund raiser, Jane Tomlinson, 43, who passed away last September. She was denied the drug, Lapatinib, because her NHS trust would not pay the £6,700 cost.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
30 September 2003
'Next big step' in breast cancer treatment launched
Cancer Research UK scientists will today embark on the next big step towards preventing breast cancer with the launch of a major new trial called IBIS II. The 10-year study will test a new drug called anastrozole and involve 10,000 healthy women who are at an increased risk of the disease.